Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PReoperative Chemoradiation With Paclitaxel-carboplatin or With Fluorouracil-oxaliplatine-acide Folinique (FOLFOX) for Resectable Esophageal and Junctional Cancer - A Randomized Phase II Trial

NCT02359968 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT02359968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02359968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PReoperative Chemoradiation With Paclitaxel-carboplatin or With Fluorouracil-oxaliplatine-acide Folinique (FOLFOX) for Resectable Esophageal and Junctional Cancer - A Randomized Phase II Trial
Lead sponsor
Centre Oscar Lambret
Phase
Phase 2
Overall status
Completed
Start date
February 26, 2015
Completion date
February 9, 2024
Enrollment
106 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal neoplasms, gastro-esophageal junction cancer